CFDE Data Portal | Search CMTM5

	Label	Description
	CMTM5 Gene (Entity type)	ENSG00000166091 - CKLF like MARVEL transmembrane domain containing 5
	CMTM5 associations Collection (Entity type)	Associations for CMTM5_associations
	CMTM5 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE261563 CX-5461 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE158431 2 V 0 PIOGLITAZONE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE214931 temozolomide 4 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE97352 1 V 2 DASATINIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE165071,GSE165072 1 V 0 DEXAMETHASONE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE214931 4 V 0 TEMOZOLOMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS

CMTM5

ENSG00000166091 - CKLF like MARVEL transmembrane domain containing 5

CMTM5 associations

Associations for CMTM5_associations

CMTM5 associations.tsv

A file from IDG as part of the Harmonizome project

GSE261563 CX-5461 6 v 1 human up

A Gene Set from LINCS

GSE158431 2 V 0 PIOGLITAZONE MOUSE UP

A Gene Set from LINCS

GSE214931 temozolomide 4 v 0 human up

A Gene Set from LINCS

GSE97352 1 V 2 DASATINIB HUMAN UP

A Gene Set from LINCS

GSE165071,GSE165072 1 V 0 DEXAMETHASONE MOUSE UP

A Gene Set from LINCS

GSE176008 pyridoxine 7 v 3 human dn

A Gene Set from LINCS

GSE214931 4 V 0 TEMOZOLOMIDE HUMAN UP

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.